Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
06/2003
06/05/2003WO2003045369A2 Use of l isomers of amino acid derivatives of hydroxyguanidine for producing no, pharmaceutical compositions containing same and pharmaceutical uses
06/05/2003WO2003045368A1 Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes
06/05/2003WO2003045367A1 Angiogenesis inhibitor
06/05/2003WO2003045363A2 Treatment of th2 dominated immunological disease states with progesterone receptor antagonists
06/05/2003WO2003045362A2 Treatment of th1 dominated immunological disease states with non-endogenous gestagen compounds
06/05/2003WO2003045328A2 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof
06/05/2003WO2003045319A2 Targeted therapeutics and uses thereof
06/05/2003WO2003045315A2 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses
06/05/2003WO2003045313A2 2-aminoquinoline compounds
06/05/2003WO2003045229A2 Methods and compositions for treating cancer
06/05/2003WO2002091988A3 Novel processes for the preparation of adenosine compounds and intermediates thereto
06/05/2003WO2002085843A3 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
06/05/2003WO2002074924A3 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof
06/05/2003WO2002064157A9 Localized myocardial injection method for treating ischemic myocardium
06/05/2003WO2002062841A3 Secreted proteins
06/05/2003WO2002060864A9 Process of obtaining compositions of stable lutein and lutein derivatives
06/05/2003WO2002060485A3 Use of immunoregulatory antibodies in the treatment of neoplastic disorders
06/05/2003WO2002048124A3 Piperazine derivatives
06/05/2003WO2002046230A3 G-protein coupled receptors
06/05/2003WO2002028863A8 New oxabispidine compound useful in the treatment of cardiac arrhythmias
06/05/2003US20030106082 Transgenic stem cells, formed by dissociating blastomeres, are cultured, impregnated within surrogate; animals models; gene therapy
06/05/2003US20030105336 Pyrazole derivatives, their preparation and their use in pharmaceuticals
06/05/2003US20030105333 RXR activating molecules
06/05/2003US20030105331 Use as anorectics, treating obesity and type II diabetes; C2-substituent is a sulfonyl-, sulfinyl- or sulfide-containing group, and indan 1-hydroxy group is esterified, etherified or a carbonate group
06/05/2003US20030105327 By-product inhibition of the diketopiperazine derivative by carrying out in aqueous liquid a series of operations under given conditions in the same solvent; making enalapril maleate for example
06/05/2003US20030105318 G-protein transmembrane domain; protein synthesis inhibitor; neurotransmitter
06/05/2003US20030105300 Carbocyanine dyes/bioconjugates; optical tomography; fluorescence endoscopy; treating atherosclerotic plaques and blood clots; laser detection of metastasis
06/05/2003US20030105299 Carbocyanine dyes for tandem, photodiagnostic and therapeutic applications
06/05/2003US20030105168 Composition comprising ubiquinone
06/05/2003US20030105165 Gap junctions and EDHF
06/05/2003US20030105151 Anticancer agents; antiinflammatory agents; autoimmune diseases; rheumatic diseases
06/05/2003US20030105150 Method of treating of demyelinating diseases or conditions
06/05/2003US20030105148 Selective estrogen receptor modulators
06/05/2003US20030105147 Analgesics, sedatives, anesthetics
06/05/2003US20030105142 Amide derivatives useful as inhibitors of the production of cytokines
06/05/2003US20030105141 Mixture containing fatty acid and aromatic amine; administering by mouth; cyclooxygenase enzyme inhibitor
06/05/2003US20030105138 Using carvedilol, or synergistic mixture thereof
06/05/2003US20030105123 For therapy of respiratory system disorders
06/05/2003US20030105118 Tricyclic quinazolinediones
06/05/2003US20030105107 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
06/05/2003US20030105106 5-HT receptor ligands and uses thereof
06/05/2003US20030105094 For therapy of metabolic disorder, an eating disorder or diabetes
06/05/2003US20030105090 For therapy of cancer, diabetes
06/05/2003US20030105088 Thiol-based NAALADase inhibitors
06/05/2003US20030105087 New polycyclic azaindole compounds
06/05/2003US20030105085 Antagonists of MCP-1 function and methods of use thereof
06/05/2003US20030105084 Compound which inhibit the release of inflammatory cytokines
06/05/2003US20030105078 Diphenyl derivatives
06/05/2003US20030105069 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
06/05/2003US20030105052 Oligoribonucleotide derivatives for specific inhibition of gene expression
06/05/2003US20030105031 Administering therapeutically effective amount of one or more flavonoids and carrier for therapy of reactive and inflammatory dermatoses
06/05/2003US20030105027 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
06/05/2003US20030104992 A cyclic polypeptides; immunosuppressive anti-inflammatory activity, inhibiting antigen-induced inflammatory cell infiltration
06/05/2003US20030104977 Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors
06/05/2003US20030104976 Analgesic methods using endothelin receptor ligands
06/05/2003US20030104975 Useful for identification of compounds that induce or inhibit the recruitment of the p160 family cofactors, especially TIF-2 and/ or SRCs cofactors (Translation initiation factor-2 and steroid receptor cofactors)
06/05/2003US20030104974 Dual inhibitorsof PDE 7 and PDE 4
06/05/2003US20030104627 Method and an apparatus for generating shockwave, a method and an apparatus for accelerating particles, an apparatus for delivering drugs, and a method and an apparatus for delivering DNA
06/05/2003US20030104625 Novel oncolytic adenoviral vectors
06/05/2003US20030104568 Monitoring electrical transfer between transgenic cell and heart muscle tissue; electroconductivity analysis; tissue engineering
06/05/2003US20030104500 Enzymatic assays for screening anti-cancer agents
06/05/2003US20030104478 Screening modulators of g-protein activity: for use in treatment of nervous system disorders
06/05/2003US20030104450 Novel regulator of g protein signalling
06/05/2003US20030104400 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of infammatory, immunol;ogical and nervous system disorders
06/05/2003US20030104377 Tenascin-C nucleic acid ligands
06/05/2003US20030104077 Relieving symptoms of erectile dysfunction with proanthocyanidins
06/05/2003US20030104045 Novel therapeutic binding molecule complexes
06/05/2003US20030103995 Detection and therapy of vulnerable plaque with photodynamic compounds
06/05/2003US20030103973 Method for reducing tumor growth with VEGF antagonists combined with radiation and chemotherapy
06/05/2003US20030103957 Comprises adenosine-diphosphate transferase activity; drug delivery; for suppressing inhibition of neuronal axon growth
06/05/2003US20030103954 Comprises vitamin D3 for regulating cell differentiation and/or cell proliferation
06/05/2003US20030103953 Comprises vitamin D3 for controlling cell differentiation and/or cell proliferation
06/05/2003US20030103943 Multiple site delivery of adenoviral vector for the induction of angiogenesis
06/05/2003US20030103912 Breaking, disrupting film in aqueous solution; preventioncoagulation
06/05/2003CA2486924A1 Use of t-cell immune response cdna 7 (tirc7) for modulation of angiogenesis and/or neovascularization
06/05/2003CA2471833A1 Methods of compositions for normalizing lipid levels in mammalian tissues
06/05/2003CA2468878A1 Antigen presenting cell targeting conjugate, an antigen presenting cell contacted with such conjugate, their use for vaccination or as medicament, and methods for their productionor generation
06/05/2003CA2468717A1 Aryl fused azapolycyclic compounds
06/05/2003CA2468705A1 Succinic acid salts of 5,8,14-triazatetracyclo'10.3.1.0<2,11>.0<4,9>-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
06/05/2003CA2468292A1 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
06/05/2003CA2468280A1 Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes
06/05/2003CA2468184A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
06/05/2003CA2468181A1 Hydroperylene derivatives
06/05/2003CA2468159A1 4-aminoquinoline compounds
06/05/2003CA2468154A1 Methods for regulating levels of zinc, cadmium and calcium in humans and for diagnosing, or screening for the risk of developing, diseases associated with abnormal levels of cadmium, zinc and calcium in body fluids and tissues
06/05/2003CA2468071A1 Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives, compositions containing same, preparation method and use thereof
06/05/2003CA2468016A1 Humanized collagen antibodies and related methods
06/05/2003CA2468015A1 2-aminoquinoline compounds
06/05/2003CA2467892A1 Methods and compositions for derepression of iap-inhibited caspase
06/05/2003CA2467825A1 Benzothiazole derivatives
06/05/2003CA2467664A1 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof
06/05/2003CA2467565A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/05/2003CA2467451A1 Method for controlling angiogenesis in animals
06/05/2003CA2467165A1 Therapeutic compounds for treating dyslipidemic conditions
06/05/2003CA2465846A1 Targeted therapeutics and uses thereof
06/05/2003CA2463592A1 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses
06/05/2003CA2413315A1 Antithrombin for the prevention and therapy of vasculoproliferative disorders
06/04/2003EP1316611A1 L-methionine gamma-lyase with modified function
06/04/2003EP1316547A1 Novel crystals of n-hydroxy-2(s)-methyl-5-ethoxymethoxy -4(s)- n-(4-phenoxyphenylcarbonyl)amino]pentanamide, process for their production and medicines containing the crystals as the active ingredient
06/04/2003EP1316313A2 Composition for the treatment of ischemic stroke containing zonampanel and a tissue plasminogen activator
1 ... 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 ... 1595